Name: Anbio Biotechnology (NNNN) Cash Flow Statement
Creator: FinSpry

Anbio Biotechnology Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for Anbio Biotechnology (NNNN) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Operating Activities
Net Income	2.37	2.25	10.01	2.54
Depreciation & Amortization	0.00	0.01	0.01	0.00
Change in Working Capital	0.04	-1.20	-5.53	1.65
Change in Accounts Receivable	0.82	-1.88	0.72	-0.72
Change in Inventory	0.00	0.35	-0.35	0.00
Change in Accounts Payable	0.80	-0.58	-0.48	1.89
Change in Other Working Capital	-1.57	0.91	0.00	0.47
Other Operating Activities	-0.34	0.00	0.00	0.00
Net Cash from Operating Activities	2.08	0.90	4.45	4.18
Investing Activities
Purchases of Investments	0.34	1.73	-16.09	0.00
Sales/Maturities of Investments	35.80	20.27	14.56	0.00
Net Cash from Investing Activities	0.34	1.73	-1.53	0.00
Financing Activities
Other Financing Activities	-0.34	-0.04	0.00	0.00
Net Cash from Financing Activities	-0.34	-0.04	0.00	0.00
Summary
Net Change in Cash	2.07	2.59	2.92	4.18
Cash at Beginning of Period	9.69	7.10	4.18	0.00
Cash at End of Period	11.76	9.69	7.10	4.18
Free Cash Flow	2.08	0.90	4.45	4.18